Publisher's Synopsis
Excerpt from How the Federal Government Can Be a Better Partner to Oregon's Biotechnology Industry: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, Second Session; Portland, Or., October 17, 1994
I think the critical element then that I am trying to emphasize here is that the time and the costs of the fda approval cycle must be reduced. Let's talk a little bit about the proposed legislation, hr. 5201. I think that that is definitely a step in the right direction and it will help biotech companies in raising capital. Any investor looks at two things when they're thinking about raising capital. That is the risk associated with their investment, and the return that they expect to get from that investment. About the Publisher Forgotten Books publishes hundreds of thousands of rare and classic books. Find more at www.forgottenbooks.com This book is a reproduction of an important historical work. Forgotten Books uses state-of-the-art technology to digitally reconstruct the work, preserving the original format whilst repairing imperfections present in the aged copy. In rare cases, an imperfection in the original, such as a blemish or missing page, may be replicated in our edition. We do, however, repair the vast majority of imperfections successfully; any imperfections that remain are intentionally left to preserve the state of such historical works.
